InvestorsHub Logo
Followers 30
Posts 2559
Boards Moderated 0
Alias Born 04/01/2009

Re: dr_lowenstein post# 29520

Sunday, 04/19/2015 6:58:32 PM

Sunday, April 19, 2015 6:58:32 PM

Post# of 48316
I did not say that they should have been mentioned.

However, with Merck and others apparently neck and neck with response/nonresponse rates, ONCS - or frankly someone else's electroporation - could give one of the companies a leg up on the others.

All I say is IMHO and not to be construed as investment advice. I know nothing, as informed frequently by my wife.